GSK has been giving Relenza to China for decades, part of a sweet deal to sell flu vaccine. Shareholders got nothing(of course) and Biota management probably had no control (as usual).
- Forums
- ASX - By Stock
- BTA
- china relenza study
china relenza study, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online